Gene therapy for the hemophilias
- 1 January 1997
- book chapter
- Published by Elsevier
- Vol. 40, 119-134
- https://doi.org/10.1016/s0065-3519(97)80006-7
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Targeted disruption of the mouse factor VIII gene produces a model of haemophilia ANature Genetics, 1995
- Efficient Transfection of Primary Cells in a Canine Hemophilia B Model Using Adenovirus–Polylysine–DNA ComplexesHuman Gene Therapy, 1994
- In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient DogsScience, 1993
- Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.The Journal of Experimental Medicine, 1992
- Absence of Anti-Human Immunodeficiency Virus Types 1 and 2 Seroconversion after the Treatment of Hemophilia A or von Willebrand's Disease with Pasteurized Factor VIII ConcentrateNew England Journal of Medicine, 1989
- A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with HemophiliaNew England Journal of Medicine, 1989
- Absence of Hepatitis after Treatment with a Pasteurized Factor VIII Concentrate in Patients with Hemophilia and No Previous TransfusionsNew England Journal of Medicine, 1987
- Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B)Biochemistry, 1985
- Structure of human factor VIIINature, 1984
- Characterization of the human factor VIII geneNature, 1984